Granting human gene patents that include broad antibody claims without any experimental antibody production makes the gene patent issue more complex. The landscape of gene patents that include ...
For the last 30 years, the production of affinity reagents and particularly antibodies for research and therapeutic applications has been dominated by hybridoma and polyclonal technologies ...
Such platforms cover all processes, from antigen design and preparation to animal immunization, via antibody production, enabling Sino Biological to screen and determine antibody molecules that ...
Anti-idiotypic antibodies (anti-ID Ab) are antibodies that identify and attach to the idiotypic center of other antibodies. Anti-idiotype antibodies are commonly employed in therapeutic drug ...
Antibodies bind to specific antigens on pathogens. This means that only one type of antibody will bind to a matching antigen. Scientists discovered that we could make antibodies to bind to ...
Antibodies bind to specific antigens on pathogens. This means that only one type of antibody will bind to a matching antigen. Scientists discovered that we could make antibodies to bind to ...
A Golden Gate-based dual-expression vector enables rapid screening, which facilitates efficient isolation of high-affinity cross-reactive antibodies for therapeutic or diagnostic use and provides a ...
Our characterization services include isotyping, variable domain sequencing, recombinant antibody validation, Western blot screening and high-throughput kinetics via Carterra LSA surface plasmon ...
New insights into the impact of checkpoint inhibitors on the immune system may enhance cancer treatment strategies. A ...
This work presents a valuable exploration of AI-assisted protein engineering, particularly in designing a VHH antibody with enhanced resistance and stability to extreme environments. However, the ...
A positive rosette is evidence of a FMH of approximately 10 mL; a quantitative test, such as the Kleihauer-Betke test, should be performed Production of anti-D antibodies by an RhD-negative mother ...